Literature DB >> 9049353

Effect of methyltransferase inhibitors on the regulation of baculovirus protein synthesis.

C Bach1, A Cramer, C Scholtissek.   

Abstract

In the presence of the methyltransferase inhibitor 3-deazaadenosine (3DA-Ado) the production of infectious Autographa californica nuclear polyhedrosis virus (AcMNPV) in tissue culture was only slightly affected, while the synthesis of very late proteins (polyhedrin and p10) was abolished. The synthesis of the influenza virus proteins NS1 and HA, expressed under the polyhedrin promoter, was also abolished by 3DA-Ado. Furthermore, 3DA-Ado interfered with the shut-off of early and late AcMNPV proteins. Most of these results were also obtained with 5-azadeoxycytidine (5A-dCyt). In cells in which NS1 was produced abundantly, at least one specific AcMNPV protein was not synthesized. However, if the production of NS1 was inhibited by 3DA-Ado, or if HA was synthesized instead, this AcMNPV protein showed up normally.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9049353     DOI: 10.1099/0022-1317-76-4-1025

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3.

Authors:  Kumar Singh Saikatendu; Jeremiah S Joseph; Vanitha Subramanian; Tom Clayton; Mark Griffith; Kin Moy; Jeffrey Velasquez; Benjamin W Neuman; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn
Journal:  Structure       Date:  2005-11       Impact factor: 5.006

2.  mRNA cap-1 methyltransferase in the SARS genome.

Authors:  Marcin von Grotthuss; Lucjan S Wyrwicz; Leszek Rychlewski
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 3.  A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects.

Authors:  Ji Xiao; Ping Liu; Yiliang Wang; Yexuan Zhu; Qiongzhen Zeng; Xiao Hu; Zhe Ren; Yifei Wang
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.